What causes Alzheimer's?

Scientist

Volumn 25, Issue 9, 2011, Pages

  Griffin, W Sue T ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052593015     PISSN: 08903670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. 42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial", Lancet, 372:216-23, 2008. (Pubitemid 351978111)
2. W. S. Griffin et al, "Manipulation of brain DNA synthesis is achieved by using a systemic immunological disease", PNAS, 79:4783-85, 1982.
3. K. E. Wisniewski et al, "Alzheimer's disease in Down's syndrome: clinicopathologic studies", Neurology, 35:957-61, 1985. (Pubitemid 15026265)
4. S. W. Barger, A. D. Harmon, "Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E", Nature, 388:878-81, 1997. (Pubitemid 27377060)
5. W. S. Griffin et al, "Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution", J Neuropathol Exp Neurol 54:276-81, 1995.
6. D. Goldgaber et al., "Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells", PNAS, 86:7606-10, 1989. (Pubitemid 19254505)
7. W. S. Griffin et al, "Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease", PNAS, 86:7611-15, 1989. (Pubitemid 19254506)
8. Y. Li et al, "Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway", J Neurosci, 23:1605-11, 2003. (Pubitemid 36314715)
9. W. S. Griffin et al, "Interleukin-1 mediates Alzheimer and Lewy body pathologies", J Neuroinflammation, 16;3:5, 2006.
10. Y. Li et al, "Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression", J Neurosci, 20:149-55, 2000. (Pubitemid 30220501)
11. J. C. Breitner et al., "Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study", Neurology, 44:227-32, 1994. (Pubitemid 24070956)
12. S. C. Vlad et al, "Protective effects of NSAIDs on the development of Alzheimer disease", Neurology, 70:1672-77, 2008. (Pubitemid 351644133)
13. J. C. Breitner et al, "Extended results of the Alzheimer's disease anti-inflammatory prevention trial", Alzheimers Dement, 7:402-11, 2011.